Viewing Study NCT03316560

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:08 AM
Ignite Modification Date: 2026-06-18 @ 3:29 PM
Study NCT ID: NCT03316560
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-05-20
First Post: 2017-10-10
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Efficacy of rAAV2tYF-GRK1-RPGR in Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations
Sponsor: Beacon Therapeutics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None X-Linked Retinitis Pigmentosa View
Keywords:

Keywords

Keyword Brief Keyword Text View
None XLRP View
None retinal degeneration View
None RPGR View
None adeno-associated virus View
None gene therapy View
None AAV View